APA

Pilorge S., Rigaudeau S., Rabian F., Sarkozy C., Taksin A. L., Farhat H., Merabet F., Ghez S., Raggueneau V., Terré C., Garcia I., Renneville A., Preudhomme C., Castaigne S. & Rousselot P. (20140515). Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse. : American journal of hematology.

Chicago

Pilorge Sylvain, Rigaudeau Sophie, Rabian Florence, Sarkozy Clémentine, Taksin Anne L, Farhat Hassan, Merabet Fathia, Ghez Stéphanie, Raggueneau Victoria, Terré Christine, Garcia Isabelle, Renneville Aline, Preudhomme Claude, Castaigne Sylvie and Rousselot Philippe. 20140515. Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse. : American journal of hematology.

Harvard

Pilorge S., Rigaudeau S., Rabian F., Sarkozy C., Taksin A. L., Farhat H., Merabet F., Ghez S., Raggueneau V., Terré C., Garcia I., Renneville A., Preudhomme C., Castaigne S. and Rousselot P. (20140515). Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse. : American journal of hematology.

MLA

Pilorge Sylvain, Rigaudeau Sophie, Rabian Florence, Sarkozy Clémentine, Taksin Anne L, Farhat Hassan, Merabet Fathia, Ghez Stéphanie, Raggueneau Victoria, Terré Christine, Garcia Isabelle, Renneville Aline, Preudhomme Claude, Castaigne Sylvie and Rousselot Philippe. Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse. : American journal of hematology. 20140515.